| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.658 | 0.012 | 0.702 | Cholesterol antagonist | 0.702 0.008 DBMET01845 0.691 0.009 DBMET01846 0.362 0.06 DBMET01847 | DBMET01845 | |
| 0.63 | 0.003 | 0.63 | TRPA1 agonist | 0.437 0.004 DBMET01845 0.582 0.003 DBMET01846 0.44 0.004 DBMET01847 | ||
| 0.62 | 0.004 | 0.62 | Anesthetic general | 0.562 0.005 DBMET01845 0.597 0.005 DBMET01846 0.278 0.039 DBMET01847 | ||
| 0.576 | 0.012 | 0.576 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.571 0.013 DBMET01845 0.575 0.012 DBMET01846 0.279 0.07 DBMET01847 | ||
| 0.554 | 0.024 | 0.557 | Thyroid hormone antagonist | 0.435 0.046 DBMET01845 0.557 0.024 DBMET01846 | DBMET01846 | |
| 0.555 | 0.025 | 0.645 | Aldehyde oxidase inhibitor | 0.625 0.016 DBMET01845 0.645 0.013 DBMET01846 0.44 0.041 DBMET01847 | DBMET01846 | |
| 0.533 | 0.01 | 0.599 | Hypolipemic | 0.59 0.007 DBMET01845 0.599 0.007 DBMET01846 | DBMET01846 | |
| 0.531 | 0.023 | 0.592 | Vasodilator, peripheral | 0.505 0.027 DBMET01845 0.592 0.017 DBMET01846 0.222 0.152 DBMET01847 | DBMET01846 | |
| 0.508 | 0.004 | 0.512 | Neurotrophic factor enhancer | 0.51 0.004 DBMET01845 0.512 0.004 DBMET01846 0.29 0.021 DBMET01847 | DBMET01846 | |
| 0.517 | 0.029 | 0.519 | Thyroid hormone beta antagonist | 0.403 0.053 DBMET01845 0.519 0.028 DBMET01846 | DBMET01846 | |
| 0.501 | 0.02 | 0.55 | Antioxidant | 0.53 0.017 DBMET01845 0.55 0.015 DBMET01846 0.476 0.023 DBMET01847 | DBMET01846 | |
| 0.542 | 0.071 | 0.602 | Antiinflammatory | 0.561 0.064 DBMET01845 0.602 0.053 DBMET01846 0.52 0.079 DBMET01847 | DBMET01846 | |
| 0.492 | 0.022 | 0.492 | 12-Lipoxygenase inhibitor | 0.445 0.029 DBMET01845 0.449 0.029 DBMET01846 0.316 0.071 DBMET01847 | ||
| 0.472 | 0.003 | 0.564 | Vanilloid agonist | 0.511 0.003 DBMET01845 0.564 0.003 DBMET01846 0.5 0.003 DBMET01847 | DBMET01846 | |
| 0.527 | 0.066 | 0.574 | Apoptosis agonist | 0.558 0.059 DBMET01845 0.557 0.059 DBMET01846 0.574 0.055 DBMET01847 | DBMET01847 | |
| 0.46 | 0.004 | 0.46 | Heat shock protein 90 alpha antagonist | 0.446 0.005 DBMET01845 0.453 0.004 DBMET01846 0.19 0.056 DBMET01847 | ||
| 0.455 | 0.009 | 0.465 | Melanin inhibitor | 0.44 0.009 DBMET01845 0.465 0.008 DBMET01846 0.414 0.011 DBMET01847 | DBMET01846 | |
| 0.471 | 0.04 | 0.471 | Histamine release inhibitor | 0.453 0.048 DBMET01845 0.466 0.043 DBMET01846 0.33 0.109 DBMET01847 | ||
| 0.451 | 0.022 | 0.473 | Free radical scavenger | 0.447 0.022 DBMET01845 0.473 0.019 DBMET01846 0.367 0.035 DBMET01847 | DBMET01846 | |
| 0.431 | 0.004 | 0.431 | Heat shock protein 90 antagonist | 0.413 0.004 DBMET01845 0.425 0.004 DBMET01846 0.152 0.073 DBMET01847 | ||
| 0.475 | 0.048 | 0.493 | Transcription factor NF kappa B inhibitor | 0.446 0.054 DBMET01845 0.493 0.045 DBMET01846 0.426 0.058 DBMET01847 | DBMET01846 | |
| 0.442 | 0.02 | 0.442 | Superoxide dismutase inhibitor | 0.348 0.037 DBMET01845 0.439 0.02 DBMET01846 0.341 0.039 DBMET01847 | ||
| 0.485 | 0.066 | 0.551 | Caspase 9 stimulant | 0.526 0.051 DBMET01845 0.551 0.044 DBMET01846 0.477 0.069 DBMET01847 | DBMET01846 | |
| 0.444 | 0.027 | 0.469 | Lipoxygenase inhibitor | 0.469 0.023 DBMET01845 0.468 0.023 DBMET01846 0.235 0.11 DBMET01847 | DBMET01845 | |
| 0.424 | 0.01 | 0.555 | 5 Hydroxytryptamine uptake stimulant | 0.369 0.021 DBMET01845 0.419 0.011 DBMET01846 0.555 0.003 DBMET01847 | DBMET01847 | |
| 0.417 | 0.013 | 0.422 | Sodium/bile acid cotransporter inhibitor | 0.399 0.017 DBMET01845 0.422 0.012 DBMET01846 0.267 0.11 DBMET01847 | DBMET01846 | |
| 0.42 | 0.018 | 0.444 | Peroxidase inhibitor | 0.404 0.02 DBMET01845 0.444 0.015 DBMET01846 0.359 0.027 DBMET01847 | DBMET01846 | |
| 0.418 | 0.019 | 0.418 | Calcium channel activator | 0.369 0.038 DBMET01845 0.399 0.025 DBMET01846 0.363 0.042 DBMET01847 | ||
| 0.451 | 0.054 | 0.451 | 15-Lipoxygenase inhibitor | 0.436 0.059 DBMET01845 0.443 0.057 DBMET01846 0.31 0.125 DBMET01847 | ||
| 0.407 | 0.017 | 0.442 | RNA-directed DNA polymerase inhibitor | 0.442 0.014 DBMET01845 0.434 0.015 DBMET01846 0.257 0.045 DBMET01847 | DBMET01845 | |
| 0.385 | 0.012 | 0.39 | Monophenol monooxygenase inhibitor | 0.362 0.013 DBMET01845 0.39 0.012 DBMET01846 0.268 0.022 DBMET01847 | DBMET01846 | |
| 0.408 | 0.036 | 0.432 | Apoptosis antagonist | 0.432 0.031 DBMET01845 0.422 0.033 DBMET01846 0.217 0.159 DBMET01847 | DBMET01845 | |
| 0.414 | 0.043 | 0.451 | Streptokinase A inhibitor | 0.451 0.036 DBMET01845 0.418 0.042 DBMET01846 0.223 0.119 DBMET01847 | DBMET01845 | |
| 0.418 | 0.054 | 0.507 | GABA C receptor rho-3 antagonist | 0.453 0.041 DBMET01845 0.453 0.041 DBMET01846 0.507 0.024 DBMET01847 | DBMET01847 | |
| 0.366 | 0.013 | 0.373 | Interferon gamma antagonist | 0.373 0.012 DBMET01845 0.366 0.013 DBMET01846 0.274 0.024 DBMET01847 | DBMET01845 | |
| 0.418 | 0.067 | 0.418 | 5 Hydroxytryptamine release inhibitor | 0.405 0.075 DBMET01845 0.39 0.085 DBMET01846 0.362 0.105 DBMET01847 | ||
| 0.357 | 0.014 | 0.362 | Tyrosine 3 hydroxylase inhibitor | 0.35 0.016 DBMET01845 0.362 0.014 DBMET01846 0.315 0.027 DBMET01847 | DBMET01846 | |
| 0.338 | 0.002 | 0.445 | Thyroid hormone alpha antagonist | 0.271 0.002 DBMET01845 0.445 0.002 DBMET01846 | DBMET01846 | |
| 0.351 | 0.019 | 0.351 | Non-steroidal antiinflammatory agent | 0.262 0.038 DBMET01845 0.333 0.022 DBMET01846 0.192 0.077 DBMET01847 | ||
| 0.323 | 0.004 | 0.336 | Vanilloid 1 agonist | 0.282 0.004 DBMET01845 0.336 0.004 DBMET01846 0.231 0.007 DBMET01847 | DBMET01846 | |
| 0.332 | 0.015 | 0.419 | Lipid peroxidase inhibitor | 0.419 0.009 DBMET01845 0.408 0.009 DBMET01846 0.176 0.052 DBMET01847 | DBMET01845 | |
| 0.329 | 0.016 | 0.358 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.307 0.022 DBMET01845 0.358 0.011 DBMET01846 0.221 0.057 DBMET01847 | DBMET01846 | |
| 0.315 | 0.005 | 0.346 | Farnesoid X receptor antagonist | 0.316 0.005 DBMET01845 0.346 0.004 DBMET01846 0.336 0.005 DBMET01847 | DBMET01846 | |
| 0.354 | 0.051 | 0.356 | Spasmolytic | 0.334 0.058 DBMET01845 0.356 0.051 DBMET01846 0.352 0.052 DBMET01847 | DBMET01846 | |
| 0.317 | 0.016 | 0.317 | Amylase inhibitor | 0.262 0.025 DBMET01845 0.268 0.024 DBMET01846 0.247 0.029 DBMET01847 | ||
| 0.347 | 0.047 | 0.353 | Interleukin 2 agonist | 0.289 0.082 DBMET01845 0.353 0.044 DBMET01846 0.294 0.078 DBMET01847 | DBMET01846 | |
| 0.315 | 0.015 | 0.335 | Protein kinase stimulant | 0.287 0.019 DBMET01845 0.335 0.013 DBMET01846 0.271 0.021 DBMET01847 | DBMET01846 | |
| 0.336 | 0.038 | 0.346 | Amyloid beta aggregation inhibitor | 0.289 0.047 DBMET01845 0.346 0.035 DBMET01846 | DBMET01846 | |
| 0.337 | 0.039 | 0.337 | Transcription factor STAT inhibitor | 0.304 0.053 DBMET01845 0.318 0.046 DBMET01846 0.293 0.06 DBMET01847 | ||
| 0.299 | 0.002 | 0.308 | Purinergic P2X2 antagonist | 0.293 0.002 DBMET01845 0.308 0.002 DBMET01846 | DBMET01846 | |
| 0.371 | 0.076 | 0.496 | Immunosuppressant | 0.436 0.051 DBMET01845 0.41 0.059 DBMET01846 0.496 0.034 DBMET01847 | DBMET01847 | |
| 0.316 | 0.023 | 0.316 | Gastrin inhibitor | 0.279 0.049 DBMET01845 0.287 0.043 DBMET01846 0.218 0.122 DBMET01847 | ||
| 0.296 | 0.006 | 0.303 | ATPase inhibitor | 0.303 0.005 DBMET01845 0.297 0.006 DBMET01846 0.218 0.025 DBMET01847 | DBMET01845 | |
| 0.305 | 0.016 | 0.343 | Alpha-N-acetylglucosaminidase inhibitor | 0.343 0.012 DBMET01845 0.307 0.015 DBMET01846 0.27 0.02 DBMET01847 | DBMET01845 | |
| 0.327 | 0.041 | 0.327 | Pyruvate kinase inhibitor | 0.272 0.055 DBMET01845 0.294 0.049 DBMET01846 0.226 0.069 DBMET01847 | ||
| 0.3 | 0.018 | 0.3 | Phospholipase C inhibitor | 0.246 0.026 DBMET01845 0.254 0.024 DBMET01846 0.272 0.021 DBMET01847 | ||
| 0.378 | 0.097 | 0.408 | Calcium channel L-type activator | 0.408 0.076 DBMET01845 0.355 0.113 DBMET01846 0.297 0.16 DBMET01847 | DBMET01845 | |
| 0.361 | 0.081 | 0.371 | Calpain 2 inhibitor | 0.371 0.076 DBMET01845 0.325 0.099 DBMET01846 | DBMET01845 | |
| 0.286 | 0.006 | 0.311 | Mannose-6-phosphate isomerase inhibitor | 0.311 0.005 DBMET01845 0.297 0.005 DBMET01846 0.188 0.037 DBMET01847 | DBMET01845 | |
| 0.323 | 0.045 | 0.352 | Antiamyloidogenic | 0.316 0.047 DBMET01845 0.352 0.038 DBMET01846 | DBMET01846 | |
| 0.388 | 0.111 | 0.388 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.384 0.115 DBMET01845 0.358 0.142 DBMET01846 0.347 0.154 DBMET01847 | ||
| 0.327 | 0.053 | 0.337 | Hypoxia-inducible factor 1 alpha inhibitor | 0.319 0.057 DBMET01845 0.337 0.049 DBMET01846 0.229 0.12 DBMET01847 | DBMET01846 | |
| 0.317 | 0.046 | 0.317 | Transcription factor STAT3 inhibitor | 0.29 0.058 DBMET01845 0.304 0.051 DBMET01846 0.302 0.053 DBMET01847 | ||
| 0.363 | 0.095 | 0.39 | Antibacterial | 0.369 0.091 DBMET01845 0.371 0.09 DBMET01846 0.39 0.081 DBMET01847 | DBMET01847 | |
| 0.282 | 0.014 | 0.282 | Anesthetic local | 0.242 0.022 DBMET01845 0.276 0.015 DBMET01846 0.132 0.059 DBMET01847 | ||
| 0.292 | 0.024 | 0.385 | Mcl-1 antagonist | 0.385 0.012 DBMET01845 0.263 0.031 DBMET01846 | DBMET01845 | |
| 0.266 | 0.004 | 0.298 | Acetyl-CoA transferase inhibitor | 0.298 0.004 DBMET01845 0.295 0.004 DBMET01846 | DBMET01845 | |
| 0.306 | 0.045 | 0.353 | Interleukin agonist | 0.302 0.047 DBMET01845 0.353 0.028 DBMET01846 0.254 0.076 DBMET01847 | DBMET01846 | |
| 0.262 | 0.007 | 0.351 | Porphobilinogen synthase inhibitor | 0.236 0.009 DBMET01845 0.276 0.006 DBMET01846 0.351 0.004 DBMET01847 | DBMET01847 | |
| 0.266 | 0.013 | 0.277 | Cystathionine beta-synthase inhibitor | 0.208 0.023 DBMET01845 0.277 0.012 DBMET01846 0.216 0.021 DBMET01847 | DBMET01846 | |
| 0.317 | 0.065 | 0.386 | 5 Hydroxytryptamine release stimulant | 0.386 0.049 DBMET01845 0.332 0.061 DBMET01846 0.353 0.056 DBMET01847 | DBMET01845 | |
| 0.269 | 0.017 | 0.4 | Succinate dehydrogenase inhibitor | 0.284 0.014 DBMET01845 0.278 0.015 DBMET01846 0.4 0.004 DBMET01847 | DBMET01847 | |
| 0.32 | 0.072 | 0.333 | Vasodilator, coronary | 0.305 0.083 DBMET01845 0.333 0.064 DBMET01846 0.209 0.174 DBMET01847 | DBMET01846 | |
| 0.265 | 0.018 | 0.296 | NADPH oxidase inhibitor | 0.296 0.013 DBMET01845 0.284 0.015 DBMET01846 0.23 0.025 DBMET01847 | DBMET01845 | |
| 0.257 | 0.015 | 0.324 | 5-Lipoxygenase inhibitor | 0.324 0.009 DBMET01845 0.302 0.01 DBMET01846 0.106 0.059 DBMET01847 | DBMET01845 | |
| 0.263 | 0.021 | 0.263 | Histone acetyltransferase inhibitor | 0.255 0.024 DBMET01845 0.246 0.027 DBMET01846 | ||
| 0.24 | 0.002 | 0.309 | Thyroid hormone alpha agonist | 0.206 0.002 DBMET01845 0.309 0.001 DBMET01846 | DBMET01846 | |
| 0.255 | 0.017 | 0.255 | Cholesterol synthesis inhibitor | 0.193 0.028 DBMET01845 0.238 0.019 DBMET01846 0.165 0.037 DBMET01847 | ||
| 0.24 | 0.003 | 0.249 | Glycine receptor agonist | 0.248 0.003 DBMET01845 0.249 0.003 DBMET01846 0.103 0.019 DBMET01847 | DBMET01846 | |
| 0.253 | 0.021 | 0.291 | Cyclooxygenase 1 inhibitor | 0.278 0.017 DBMET01845 0.291 0.015 DBMET01846 | DBMET01846 | |
| 0.258 | 0.027 | 0.258 | Nitric-oxide synthase stimulant | 0.254 0.03 DBMET01845 0.256 0.028 DBMET01846 0.231 0.048 DBMET01847 | ||
| 0.285 | 0.055 | 0.357 | Angiogenesis stimulant | 0.214 0.087 DBMET01845 0.288 0.054 DBMET01846 0.357 0.031 DBMET01847 | DBMET01847 | |
| 0.271 | 0.046 | 0.32 | Nitric oxide antagonist | 0.272 0.046 DBMET01845 0.308 0.039 DBMET01846 0.32 0.037 DBMET01847 | DBMET01847 | |
| 0.228 | 0.003 | 0.229 | Heat shock protein 90 beta antagonist | 0.188 0.004 DBMET01845 0.229 0.003 DBMET01846 0.056 0.047 DBMET01847 | DBMET01846 | |
| 0.231 | 0.011 | 0.231 | Arachidonic acid antagonist | 0.224 0.014 DBMET01845 0.231 0.011 DBMET01846 0.221 0.016 DBMET01847 | ||
| 0.221 | 0.008 | 0.221 | HIV-1 integrase (Overall Integration) inhibitor | 0.208 0.01 DBMET01845 0.2 0.012 DBMET01846 0.155 0.024 DBMET01847 | ||
| 0.338 | 0.131 | 0.426 | Cyclophilin D inhibitor | 0.385 0.099 DBMET01845 0.423 0.079 DBMET01846 0.426 0.077 DBMET01847 | DBMET01847 | |
| 0.275 | 0.069 | 0.275 | Aryl hydrocarbon receptor agonist | 0.227 0.089 DBMET01845 0.218 0.093 DBMET01846 | ||
| 0.23 | 0.025 | 0.251 | Nav1.2 sodium channel blocker | 0.251 0.022 DBMET01845 0.227 0.026 DBMET01846 | DBMET01845 | |
| 0.21 | 0.008 | 0.21 | Keratolytic | 0.162 0.013 DBMET01845 0.207 0.008 DBMET01846 0.147 0.015 DBMET01847 | ||
| 0.218 | 0.016 | 0.227 | UDP-glucose 4-epimerase inhibitor | 0.2 0.018 DBMET01845 0.227 0.015 DBMET01846 0.191 0.019 DBMET01847 | DBMET01846 | |
| 0.277 | 0.074 | 0.277 | Insulysin inhibitor | 0.239 0.107 DBMET01845 0.248 0.098 DBMET01846 0.257 0.09 DBMET01847 | ||
| 0.207 | 0.01 | 0.207 | Triose-phosphate isomerase inhibitor | 0.203 0.01 DBMET01845 0.181 0.013 DBMET01846 0.199 0.011 DBMET01847 | ||
| 0.202 | 0.007 | 0.21 | Sphingosine 1-phosphate receptor 2 antagonist | 0.207 0.006 DBMET01845 0.21 0.006 DBMET01846 0.128 0.079 DBMET01847 | DBMET01846 | |
| 0.214 | 0.019 | 0.287 | Ferrochelatase inhibitor | 0.245 0.014 DBMET01845 0.221 0.018 DBMET01846 0.287 0.009 DBMET01847 | DBMET01847 | |
| 0.2 | 0.014 | 0.2 | Potassium channel (Ca-activated) activator | 0.164 0.024 DBMET01845 0.198 0.015 DBMET01846 | ||
| 0.204 | 0.019 | 0.214 | CF transmembrane conductance regulator agonist | 0.161 0.058 DBMET01845 0.187 0.031 DBMET01846 0.214 0.015 DBMET01847 | DBMET01847 | |
| 0.197 | 0.015 | 0.214 | Adenylate cyclase stimulant | 0.18 0.026 DBMET01845 0.197 0.015 DBMET01846 0.214 0.009 DBMET01847 | DBMET01847 | |
| 0.185 | 0.003 | 0.185 | Estrogen-related receptor beta agonist | 0.168 0.003 DBMET01845 0.167 0.003 DBMET01846 0.118 0.011 DBMET01847 | ||
| 0.328 | 0.146 | 0.437 | Alpha-glucosidase inhibitor | 0.283 0.169 DBMET01845 0.278 0.171 DBMET01846 0.437 0.1 DBMET01847 | DBMET01847 | |
| 0.219 | 0.04 | 0.219 | Protein-tyrosine phosphatase inhibitor | 0.167 0.064 DBMET01845 0.218 0.04 DBMET01846 0.189 0.051 DBMET01847 | ||
| 0.201 | 0.024 | 0.201 | Chelator | 0.189 0.027 DBMET01845 0.191 0.026 DBMET01846 0.116 0.058 DBMET01847 | ||
| 0.183 | 0.006 | 0.188 | Ca2+-transporting ATPase inhibitor | 0.188 0.005 DBMET01845 0.183 0.005 DBMET01846 0.171 0.013 DBMET01847 | DBMET01845 | |
| 0.19 | 0.014 | 0.231 | Estrogen antagonist | 0.177 0.016 DBMET01845 0.231 0.01 DBMET01846 0.207 0.012 DBMET01847 | DBMET01846 | |
| 0.207 | 0.031 | 0.207 | M18 aspartyl aminopeptidase inhibitor | 0.139 0.058 DBMET01845 0.171 0.043 DBMET01846 0.124 0.068 DBMET01847 | ||
| 0.227 | 0.051 | 0.261 | Hepatoprotectant | 0.261 0.04 DBMET01845 0.253 0.042 DBMET01846 0.188 0.073 DBMET01847 | DBMET01845 | |
| 0.188 | 0.013 | 0.19 | Creatine kinase inhibitor | 0.19 0.012 DBMET01845 0.179 0.015 DBMET01846 0.17 0.017 DBMET01847 | DBMET01845 | |
| 0.185 | 0.012 | 0.222 | Prolactin inhibitor | 0.209 0.007 DBMET01845 0.222 0.006 DBMET01846 0.119 0.039 DBMET01847 | DBMET01846 | |
| 0.18 | 0.006 | 0.18 | TRPA1 antagonist | 0.122 0.014 DBMET01845 0.161 0.008 DBMET01846 0.078 0.027 DBMET01847 | ||
| 0.248 | 0.078 | 0.604 | Hypoglycemic | 0.244 0.08 DBMET01845 0.262 0.07 DBMET01846 0.604 0.008 DBMET01847 | DBMET01847 | |
| 0.202 | 0.034 | 0.23 | Hexokinase inhibitor | 0.182 0.048 DBMET01845 0.182 0.048 DBMET01846 0.23 0.022 DBMET01847 | DBMET01847 | |
| 0.17 | 0.004 | 0.17 | GABA B receptor agonist | 0.148 0.004 DBMET01845 0.157 0.004 DBMET01846 0.073 0.058 DBMET01847 | ||
| 0.278 | 0.112 | 0.278 | Prostaglandin dehydrogenase inhibitor | 0.244 0.13 DBMET01845 0.244 0.13 DBMET01846 0.19 0.164 DBMET01847 | ||
| 0.174 | 0.012 | 0.175 | DOPA decarboxylase inhibitor | 0.166 0.014 DBMET01845 0.175 0.012 DBMET01846 0.157 0.018 DBMET01847 | DBMET01846 | |
| 0.173 | 0.012 | 0.216 | Estrogen receptor beta antagonist | 0.14 0.019 DBMET01845 0.207 0.009 DBMET01846 0.216 0.009 DBMET01847 | DBMET01847 | |
| 0.174 | 0.013 | 0.186 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.157 0.017 DBMET01845 0.186 0.011 DBMET01846 0.091 0.042 DBMET01847 | DBMET01846 | |
| 0.183 | 0.024 | 0.21 | GABA C receptor agonist | 0.21 0.019 DBMET01845 0.21 0.019 DBMET01846 0.137 0.039 DBMET01847 | DBMET01846 | |
| 0.184 | 0.025 | 0.184 | Cyclooxygenase 3 inhibitor | 0.177 0.029 DBMET01845 0.175 0.03 DBMET01846 0.126 0.071 DBMET01847 | ||
| 0.176 | 0.019 | 0.222 | GABA C receptor antagonist | 0.197 0.013 DBMET01845 0.192 0.014 DBMET01846 0.222 0.009 DBMET01847 | DBMET01847 | |
| 0.185 | 0.033 | 0.185 | Protein-tyrosine phosphatase 1B inhibitor | 0.139 0.05 DBMET01845 0.182 0.034 DBMET01846 0.169 0.039 DBMET01847 | ||
| 0.177 | 0.026 | 0.183 | Sphingosine 1-phosphate receptor 5 antagonist | 0.183 0.021 DBMET01845 0.182 0.022 DBMET01846 0.124 0.114 DBMET01847 | DBMET01845 | |
| 0.238 | 0.087 | 0.27 | DNA damaging | 0.27 0.07 DBMET01845 0.256 0.077 DBMET01846 | DBMET01845 | |
| 0.169 | 0.019 | 0.169 | Heat shock protein 70 antagonist | 0.149 0.048 DBMET01845 0.158 0.03 DBMET01846 0.161 0.027 DBMET01847 | ||
| 0.231 | 0.081 | 0.282 | DNA synthesis inhibitor | 0.263 0.059 DBMET01845 0.246 0.069 DBMET01846 0.282 0.05 DBMET01847 | DBMET01847 | |
| 0.194 | 0.044 | 0.203 | Interleukin 6 antagonist | 0.154 0.083 DBMET01845 0.203 0.039 DBMET01846 | DBMET01846 | |
| 0.17 | 0.021 | 0.178 | Photosensitizer | 0.156 0.028 DBMET01845 0.178 0.019 DBMET01846 0.167 0.023 DBMET01847 | DBMET01846 | |
| 0.155 | 0.007 | 0.155 | Bile acid receptor antagonist | 0.139 0.01 DBMET01845 0.146 0.008 DBMET01846 0.112 0.028 DBMET01847 | ||
| 0.17 | 0.023 | 0.226 | Mucolytic | 0.194 0.015 DBMET01845 0.196 0.014 DBMET01846 0.226 0.009 DBMET01847 | DBMET01847 | |
| 0.179 | 0.033 | 0.179 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.161 0.054 DBMET01845 0.173 0.04 DBMET01846 | ||
| 0.188 | 0.042 | 0.188 | Neurotensin receptor agonist | 0.178 0.052 DBMET01845 0.178 0.052 DBMET01846 0.149 0.103 DBMET01847 | ||
| 0.172 | 0.026 | 0.172 | GABA receptor agonist | 0.143 0.04 DBMET01845 0.16 0.031 DBMET01846 | ||
| 0.155 | 0.01 | 0.159 | Potassium channel large-conductance Ca-activated activator | 0.094 0.027 DBMET01845 0.159 0.01 DBMET01846 | DBMET01846 | |
| 0.165 | 0.022 | 0.165 | Sphingosine 1-phosphate receptor 4 antagonist | 0.153 0.031 DBMET01845 0.16 0.025 DBMET01846 0.118 0.076 DBMET01847 | ||
| 0.154 | 0.012 | 0.173 | CDC25A inhibitor | 0.16 0.011 DBMET01845 0.173 0.009 DBMET01846 0.099 0.028 DBMET01847 | DBMET01846 | |
| 0.145 | 0.004 | 0.145 | Acetyl-CoA transferase 1 inhibitor | 0.144 0.004 DBMET01845 0.141 0.004 DBMET01846 | ||
| 0.198 | 0.058 | 0.216 | Lipocortins synthesis antagonist | 0.216 0.047 DBMET01845 0.205 0.053 DBMET01846 | DBMET01845 | |
| 0.168 | 0.028 | 0.179 | Pregnane X receptor agonist | 0.179 0.02 DBMET01845 0.172 0.024 DBMET01846 | DBMET01845 | |
| 0.198 | 0.059 | 0.198 | Amyloid beta precursor protein antagonist | 0.146 0.106 DBMET01845 0.159 0.091 DBMET01846 | ||
| 0.15 | 0.011 | 0.15 | Ornithine decarboxylase inhibitor | 0.149 0.011 DBMET01845 0.147 0.012 DBMET01846 0.125 0.023 DBMET01847 | ||
| 0.172 | 0.036 | 0.195 | Aldehyde dehydrogenase inhibitor | 0.195 0.029 DBMET01845 0.181 0.033 DBMET01846 0.141 0.053 DBMET01847 | DBMET01845 | |
| 0.184 | 0.049 | 0.202 | Cyclooxygenase inhibitor | 0.199 0.042 DBMET01845 0.202 0.041 DBMET01846 | DBMET01846 | |
| 0.161 | 0.027 | 0.161 | Carbonic anhydrase XV inhibitor | 0.111 0.054 DBMET01845 0.133 0.038 DBMET01846 0.132 0.039 DBMET01847 | ||
| 0.145 | 0.011 | 0.163 | Glutamate release inhibitor | 0.163 0.007 DBMET01845 0.142 0.012 DBMET01846 | DBMET01845 | |
| 0.164 | 0.031 | 0.176 | Beta amyloid protein antagonist | 0.161 0.033 DBMET01845 0.176 0.026 DBMET01846 | DBMET01846 | |
| 0.259 | 0.128 | 0.259 | Thioredoxin glutathione reductase inhibitor | 0.21 0.164 DBMET01845 0.228 0.15 DBMET01846 | ||
| 0.202 | 0.072 | 0.245 | Insulin sensitizer | 0.217 0.058 DBMET01845 0.21 0.063 DBMET01846 0.245 0.037 DBMET01847 | DBMET01847 | |
| 0.133 | 0.004 | 0.14 | Retinoid X alpha receptor agonist | 0.137 0.003 DBMET01845 0.14 0.003 DBMET01846 0.103 0.005 DBMET01847 | DBMET01846 | |
| 0.153 | 0.023 | 0.167 | Beta glucuronidase inhibitor | 0.129 0.038 DBMET01845 0.132 0.036 DBMET01846 0.167 0.019 DBMET01847 | DBMET01847 | |
| 0.155 | 0.025 | 0.165 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.158 0.024 DBMET01845 0.136 0.032 DBMET01846 0.165 0.023 DBMET01847 | DBMET01847 | |
| 0.16 | 0.031 | 0.25 | Expectorant | 0.183 0.024 DBMET01845 0.191 0.022 DBMET01846 0.25 0.013 DBMET01847 | DBMET01847 | |
| 0.161 | 0.032 | 0.174 | Microtubule formation inhibitor | 0.174 0.027 DBMET01845 0.173 0.028 DBMET01846 0.17 0.029 DBMET01847 | DBMET01845 | |
| 0.157 | 0.028 | 0.171 | Papain-like protease (SARS coronavirus) inhibitor | 0.127 0.065 DBMET01845 0.154 0.03 DBMET01846 0.171 0.019 DBMET01847 | DBMET01847 | |
| 0.252 | 0.124 | 0.295 | Antithrombotic | 0.295 0.091 DBMET01845 0.256 0.121 DBMET01846 | DBMET01845 | |
| 0.147 | 0.019 | 0.16 | Anabolic | 0.153 0.016 DBMET01845 0.16 0.013 DBMET01846 0.158 0.014 DBMET01847 | DBMET01846 | |
| 0.148 | 0.023 | 0.171 | Androgen antagonist | 0.139 0.025 DBMET01845 0.171 0.017 DBMET01846 0.115 0.036 DBMET01847 | DBMET01846 | |
| 0.166 | 0.042 | 0.173 | Toll-Like receptor 2 antagonist | 0.173 0.038 DBMET01845 0.153 0.051 DBMET01846 0.171 0.039 DBMET01847 | DBMET01845 | |
| 0.133 | 0.009 | 0.133 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.074 0.028 DBMET01845 0.106 0.015 DBMET01846 0.096 0.018 DBMET01847 | ||
| 0.141 | 0.018 | 0.141 | Macrophage migration inhibitory factor inhibitor | 0.101 0.034 DBMET01845 0.131 0.021 DBMET01846 0.087 0.044 DBMET01847 | ||
| 0.178 | 0.055 | 0.189 | Phospholipase A2 inhibitor | 0.189 0.049 DBMET01845 0.175 0.057 DBMET01846 | DBMET01845 | |
| 0.134 | 0.012 | 0.141 | ATPase (Vacuolar H+) inhibitor | 0.141 0.01 DBMET01845 0.131 0.014 DBMET01846 0.107 0.031 DBMET01847 | DBMET01845 | |
| 0.135 | 0.014 | 0.158 | Estrogen receptor alpha antagonist | 0.13 0.016 DBMET01845 0.158 0.011 DBMET01846 0.154 0.011 DBMET01847 | DBMET01846 | |
| 0.168 | 0.049 | 0.229 | Alkaline phosphatase inhibitor | 0.143 0.065 DBMET01845 0.15 0.06 DBMET01846 0.229 0.025 DBMET01847 | DBMET01847 | |
| 0.139 | 0.02 | 0.178 | ABCA1 expression enhancer | 0.143 0.019 DBMET01845 0.143 0.019 DBMET01846 0.178 0.012 DBMET01847 | DBMET01847 | |
| 0.145 | 0.026 | 0.145 | Urease inhibitor | 0.143 0.027 DBMET01845 0.137 0.031 DBMET01846 0.099 0.068 DBMET01847 | ||
| 0.148 | 0.029 | 0.151 | Mediator release inhibitor | 0.147 0.03 DBMET01845 0.151 0.028 DBMET01846 | DBMET01846 | |
| 0.136 | 0.018 | 0.136 | Interleukin 12 antagonist | 0.097 0.059 DBMET01845 0.115 0.034 DBMET01846 | ||
| 0.151 | 0.033 | 0.191 | Nav1.4 sodium channel blocker | 0.191 0.021 DBMET01845 0.188 0.022 DBMET01846 | DBMET01845 | |
| 0.15 | 0.034 | 0.15 | Interleukin 8 antagonist | 0.115 0.068 DBMET01845 0.132 0.048 DBMET01846 | ||
| 0.12 | 0.004 | 0.12 | Heme oxygenase stimulant | 0.116 0.005 DBMET01845 0.116 0.005 DBMET01846 0.062 0.039 DBMET01847 | ||
| 0.117 | 0.002 | 0.164 | Thyroid hormone agonist | 0.095 0.003 DBMET01845 0.164 0.002 DBMET01846 0.027 0.016 DBMET01847 | DBMET01846 | |
| 0.214 | 0.1 | 0.214 | Calpain inhibitor | 0.213 0.101 DBMET01845 0.19 0.123 DBMET01846 | ||
| 0.143 | 0.029 | 0.143 | Transcription factor STAT6 inhibitor | 0.129 0.045 DBMET01845 0.138 0.034 DBMET01846 0.118 0.063 DBMET01847 | ||
| 0.156 | 0.043 | 0.156 | Proteasome inhibitor | 0.116 0.068 DBMET01845 0.139 0.053 DBMET01846 0.118 0.067 DBMET01847 | ||
| 0.134 | 0.022 | 0.147 | NADH dehydrogenase inhibitor | 0.147 0.018 DBMET01845 0.139 0.021 DBMET01846 0.122 0.028 DBMET01847 | DBMET01845 | |
| 0.22 | 0.109 | 0.254 | Immunostimulant | 0.23 0.105 DBMET01845 0.254 0.094 DBMET01846 0.217 0.11 DBMET01847 | DBMET01846 | |
| 0.194 | 0.083 | 0.206 | DNA methylase inhibitor | 0.206 0.075 DBMET01845 0.205 0.076 DBMET01846 | DBMET01845 | |
| 0.141 | 0.032 | 0.141 | Carbonic anhydrase III inhibitor | 0.1 0.062 DBMET01845 0.124 0.042 DBMET01846 0.115 0.048 DBMET01847 | ||
| 0.122 | 0.014 | 0.166 | Estrogen agonist | 0.098 0.018 DBMET01845 0.166 0.01 DBMET01846 0.157 0.011 DBMET01847 | DBMET01846 | |
| 0.112 | 0.004 | 0.116 | Retinoid X receptor agonist | 0.116 0.004 DBMET01845 0.116 0.004 DBMET01846 0.106 0.004 DBMET01847 | DBMET01846 | |
| 0.114 | 0.008 | 0.139 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.102 0.01 DBMET01845 0.139 0.005 DBMET01846 0.102 0.01 DBMET01847 | DBMET01846 | |
| 0.275 | 0.17 | 0.275 | Transcription factor inhibitor | 0.251 0.186 DBMET01845 0.241 0.193 DBMET01846 0.251 0.186 DBMET01847 | ||
| 0.124 | 0.024 | 0.143 | Phosphofructokinase-1 inhibitor | 0.115 0.027 DBMET01845 0.134 0.021 DBMET01846 0.143 0.019 DBMET01847 | DBMET01847 | |
| 0.12 | 0.019 | 0.159 | HIV-1 integrase (3'-Processing) inhibitor | 0.159 0.013 DBMET01845 0.128 0.017 DBMET01846 0.133 0.016 DBMET01847 | DBMET01845 | |
| 0.105 | 0.006 | 0.105 | TRPM8 blocker | 0.055 0.013 DBMET01845 0.06 0.012 DBMET01846 0.048 0.017 DBMET01847 | ||
| 0.148 | 0.051 | 0.164 | Interleukin 4 antagonist | 0.164 0.039 DBMET01845 0.151 0.048 DBMET01846 0.16 0.042 DBMET01847 | DBMET01845 | |
| 0.114 | 0.017 | 0.114 | D-Ala-D-Ala ligase inhibitor | 0.107 0.022 DBMET01845 0.112 0.018 DBMET01846 0.104 0.024 DBMET01847 | ||
| 0.16 | 0.064 | 0.165 | NOS3 expression enhancer | 0.121 0.113 DBMET01845 0.129 0.1 DBMET01846 0.165 0.059 DBMET01847 | DBMET01847 | |
| 0.111 | 0.016 | 0.138 | Alcohol oxidase inhibitor | 0.138 0.012 DBMET01845 0.124 0.013 DBMET01846 0.09 0.021 DBMET01847 | DBMET01845 | |
| 0.119 | 0.023 | 0.134 | Glutathione S-transferase inhibitor | 0.091 0.047 DBMET01845 0.109 0.029 DBMET01846 0.134 0.016 DBMET01847 | DBMET01847 | |
| 0.169 | 0.075 | 0.174 | 3C-like protease (Human coronavirus) inhibitor | 0.155 0.093 DBMET01845 0.155 0.093 DBMET01846 0.174 0.07 DBMET01847 | DBMET01847 | |
| 0.114 | 0.02 | 0.156 | Phenylalanine 4-hydroxylase inhibitor | 0.103 0.024 DBMET01845 0.114 0.02 DBMET01846 0.156 0.011 DBMET01847 | DBMET01847 | |
| 0.099 | 0.005 | 0.12 | Dihydroorotate oxidase inhibitor | 0.12 0.004 DBMET01845 0.111 0.004 DBMET01846 0.084 0.009 DBMET01847 | DBMET01845 | |
| 0.112 | 0.018 | 0.18 | HIV-1 integrase (Strand Transfer) inhibitor | 0.18 0.011 DBMET01845 0.123 0.016 DBMET01846 0.132 0.015 DBMET01847 | DBMET01845 | |
| 0.108 | 0.015 | 0.11 | CC chemokine 5 receptor agonist | 0.11 0.013 DBMET01845 0.101 0.021 DBMET01846 0.087 0.044 DBMET01847 | DBMET01845 | |
| 0.099 | 0.006 | 0.099 | Calcium channel P-type blocker | 0.092 0.008 DBMET01845 0.097 0.006 DBMET01846 0.085 0.011 DBMET01847 | ||
| 0.107 | 0.014 | 0.108 | Purinergic P2X1 antagonist | 0.091 0.02 DBMET01845 0.108 0.014 DBMET01846 0.093 0.019 DBMET01847 | DBMET01846 | |
| 0.165 | 0.074 | 0.165 | Catenin beta inhibitor | 0.146 0.115 DBMET01845 0.139 0.135 DBMET01846 | ||
| 0.114 | 0.023 | 0.138 | Glutamate decarboxylase inhibitor | 0.13 0.017 DBMET01845 0.116 0.022 DBMET01846 0.138 0.015 DBMET01847 | DBMET01847 | |
| 0.147 | 0.058 | 0.18 | Toll-Like receptor antagonist | 0.18 0.038 DBMET01845 0.137 0.066 DBMET01846 | DBMET01845 | |
| 0.115 | 0.027 | 0.119 | Histidine decarboxylase inhibitor | 0.076 0.046 DBMET01845 0.119 0.026 DBMET01846 0.093 0.035 DBMET01847 | DBMET01846 | |
| 0.126 | 0.039 | 0.15 | Adenylate kinase inhibitor | 0.139 0.031 DBMET01845 0.133 0.034 DBMET01846 0.15 0.026 DBMET01847 | DBMET01847 | |
| 0.091 | 0.004 | 0.103 | Geranyltranstransferase inhibitor | 0.103 0.003 DBMET01845 0.085 0.004 DBMET01846 | DBMET01845 | |
| 0.108 | 0.022 | 0.11 | GABA aminotransferase inhibitor | 0.099 0.028 DBMET01845 0.097 0.029 DBMET01846 0.11 0.021 DBMET01847 | DBMET01847 | |
| 0.1 | 0.015 | 0.103 | Peroxisome proliferator-activated receptor gamma antagonist | 0.092 0.02 DBMET01845 0.103 0.014 DBMET01846 0.071 0.05 DBMET01847 | DBMET01846 | |
| 0.139 | 0.056 | 0.193 | DNA polymerase I inhibitor | 0.193 0.03 DBMET01845 0.167 0.04 DBMET01846 | DBMET01845 | |
| 0.13 | 0.047 | 0.133 | Aminopeptidase B inhibitor | 0.133 0.046 DBMET01845 0.119 0.053 DBMET01846 0.094 0.069 DBMET01847 | DBMET01845 | |
| 0.111 | 0.029 | 0.111 | GABA A receptor agonist | 0.098 0.039 DBMET01845 0.101 0.037 DBMET01846 | ||
| 0.087 | 0.005 | 0.111 | Alpha 1L adrenoreceptor antagonist | 0.093 0.005 DBMET01845 0.111 0.004 DBMET01846 | DBMET01846 | |
| 0.086 | 0.005 | 0.086 | Cholesterol esterase inhibitor | 0.081 0.006 DBMET01845 0.077 0.008 DBMET01846 | ||
| 0.107 | 0.026 | 0.131 | Glycine receptor antagonist | 0.102 0.031 DBMET01845 0.108 0.025 DBMET01846 0.131 0.013 DBMET01847 | DBMET01847 | |
| 0.136 | 0.055 | 0.136 | Adenylate cyclase inhibitor | 0.097 0.087 DBMET01845 0.122 0.066 DBMET01846 0.127 0.062 DBMET01847 | ||
| 0.09 | 0.01 | 0.142 | Potassium channel Kv1.3 blocker | 0.142 0.005 DBMET01845 0.107 0.007 DBMET01846 0.092 0.009 DBMET01847 | DBMET01845 | |
| 0.123 | 0.043 | 0.181 | Electron transport complex I inhibitor | 0.123 0.043 DBMET01845 0.131 0.035 DBMET01846 0.181 0.011 DBMET01847 | DBMET01847 | |
| 0.086 | 0.007 | 0.098 | Urate transporter 1 inhibitor | 0.076 0.009 DBMET01845 0.098 0.005 DBMET01846 | DBMET01846 | |
| 0.081 | 0.002 | 0.123 | Thyroid hormone beta agonist | 0.055 0.003 DBMET01845 0.123 0.002 DBMET01846 | DBMET01846 | |
| 0.12 | 0.042 | 0.12 | Gastric antisecretory | 0.107 0.056 DBMET01845 0.111 0.052 DBMET01846 | ||
| 0.14 | 0.062 | 0.14 | M17 leucyl aminopeptidase inhibitor | 0.121 0.077 DBMET01846 | ||
| 0.084 | 0.007 | 0.095 | Ryanodine receptor antagonist | 0.085 0.007 DBMET01845 0.095 0.005 DBMET01846 0.065 0.025 DBMET01847 | DBMET01846 | |
| 0.16 | 0.083 | 0.184 | Antipruritic | 0.184 0.06 DBMET01845 0.161 0.083 DBMET01846 | DBMET01845 | |
| 0.097 | 0.019 | 0.14 | Biliverdin reductase inhibitor | 0.112 0.015 DBMET01845 0.096 0.02 DBMET01846 0.14 0.01 DBMET01847 | DBMET01847 | |
| 0.104 | 0.028 | 0.108 | Na+ K+ transporting ATPase inhibitor | 0.106 0.026 DBMET01845 0.106 0.027 DBMET01846 0.108 0.024 DBMET01847 | DBMET01847 | |
| 0.082 | 0.006 | 0.086 | Dopamine D5 agonist | 0.077 0.007 DBMET01845 0.086 0.005 DBMET01846 0.06 0.012 DBMET01847 | DBMET01846 | |
| 0.135 | 0.061 | 0.135 | Antibacterial (Helicobacter pylori) | 0.125 0.074 DBMET01845 0.13 0.068 DBMET01846 | ||
| 0.104 | 0.03 | 0.125 | 3C-Like protease (SARS coronavirus) inhibitor | 0.125 0.017 DBMET01845 0.099 0.034 DBMET01846 | DBMET01845 | |
| 0.167 | 0.093 | 0.171 | P-glycoprotein inhibitor | 0.147 0.121 DBMET01845 0.171 0.089 DBMET01846 | DBMET01846 | |
| 0.102 | 0.029 | 0.117 | Glutamate dehydrogenase inhibitor | 0.106 0.028 DBMET01845 0.097 0.032 DBMET01846 0.117 0.023 DBMET01847 | DBMET01847 | |
| 0.092 | 0.019 | 0.1 | CDC25B inhibitor | 0.093 0.019 DBMET01845 0.1 0.016 DBMET01846 | DBMET01846 | |
| 0.085 | 0.013 | 0.092 | Sphingosine kinase 2 inhibitor | 0.075 0.018 DBMET01845 0.075 0.018 DBMET01846 0.092 0.01 DBMET01847 | DBMET01847 | |
| 0.076 | 0.004 | 0.081 | Alpha 1L adrenoreceptor agonist | 0.081 0.004 DBMET01845 0.081 0.004 DBMET01846 | DBMET01846 | |
| 0.164 | 0.092 | 0.164 | Platelet adhesion inhibitor | 0.145 0.112 DBMET01845 0.146 0.11 DBMET01846 0.145 0.112 DBMET01847 | ||
| 0.09 | 0.019 | 0.096 | Androgen agonist | 0.092 0.018 DBMET01845 0.096 0.016 DBMET01846 0.071 0.03 DBMET01847 | DBMET01846 | |
| 0.099 | 0.028 | 0.1 | Aminopeptidase I inhibitor | 0.1 0.028 DBMET01845 0.091 0.033 DBMET01846 0.079 0.043 DBMET01847 | DBMET01845 | |
| 0.139 | 0.068 | 0.158 | Nav1.6 sodium channel blocker | 0.148 0.056 DBMET01845 0.158 0.045 DBMET01846 | DBMET01846 | |
| 0.073 | 0.004 | 0.075 | Retinoid X receptor antagonist | 0.075 0.003 DBMET01845 0.071 0.004 DBMET01846 0.062 0.005 DBMET01847 | DBMET01845 | |
| 0.097 | 0.029 | 0.097 | Prostaglandin-E synthase inhibitor | 0.089 0.033 DBMET01845 0.078 0.04 DBMET01846 | ||
| 0.077 | 0.008 | 0.077 | Pregnane X receptor antagonist | 0.075 0.01 DBMET01845 0.075 0.01 DBMET01846 0.075 0.009 DBMET01847 | ||
| 0.083 | 0.015 | 0.083 | Botulinum neurotoxin type A inhibitor | 0.073 0.022 DBMET01845 0.077 0.019 DBMET01846 0.071 0.024 DBMET01847 | ||
| 0.179 | 0.112 | 0.181 | Cyclic AMP phosphodiesterase inhibitor | 0.153 0.148 DBMET01845 0.181 0.11 DBMET01846 | DBMET01846 | |
| 0.11 | 0.042 | 0.118 | Lanosterol 14 alpha demethylase inhibitor | 0.118 0.032 DBMET01845 0.104 0.05 DBMET01846 0.093 0.066 DBMET01847 | DBMET01845 | |
| 0.195 | 0.128 | 0.195 | Neuropeptide Y2 antagonist | 0.187 0.144 DBMET01845 0.175 0.17 DBMET01846 | ||
| 0.178 | 0.111 | 0.187 | 5 Hydroxytryptamine 3E antagonist | 0.187 0.088 DBMET01845 0.182 0.1 DBMET01846 0.164 0.156 DBMET01847 | DBMET01845 | |
| 0.08 | 0.014 | 0.164 | Estrogen receptor beta agonist | 0.051 0.019 DBMET01845 0.11 0.01 DBMET01846 0.164 0.006 DBMET01847 | DBMET01847 | |
| 0.099 | 0.034 | 0.108 | mTOR complex 2 inhibitor | 0.108 0.025 DBMET01845 0.103 0.03 DBMET01846 | DBMET01845 | |
| 0.198 | 0.134 | 0.227 | 5 Hydroxytryptamine 1E antagonist | 0.171 0.165 DBMET01845 0.227 0.101 DBMET01847 | DBMET01847 | |
| 0.076 | 0.013 | 0.094 | Estrogen receptor alpha agonist | 0.05 0.017 DBMET01845 0.094 0.009 DBMET01846 0.065 0.014 DBMET01847 | DBMET01846 | |
| 0.077 | 0.014 | 0.077 | 5 Hydroxytryptamine 7 agonist | 0.058 0.034 DBMET01845 0.067 0.022 DBMET01846 | ||
| 0.067 | 0.005 | 0.067 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.067 0.005 DBMET01845 0.066 0.005 DBMET01846 0.061 0.007 DBMET01847 | ||
| 0.083 | 0.021 | 0.089 | Glutamate (mGluR6) antagonist | 0.089 0.016 DBMET01845 0.085 0.019 DBMET01846 0.076 0.029 DBMET01847 | DBMET01845 | |
| 0.079 | 0.018 | 0.086 | Corticotropin releasing factor 2 receptor antagonist | 0.081 0.016 DBMET01845 0.086 0.013 DBMET01846 | DBMET01846 | |
| 0.143 | 0.083 | 0.179 | GABA C receptor rho-2 antagonist | 0.158 0.064 DBMET01845 0.158 0.064 DBMET01846 0.179 0.043 DBMET01847 | DBMET01847 | |
| 0.212 | 0.152 | 0.337 | Caspase 3 stimulant | 0.224 0.139 DBMET01846 0.337 0.063 DBMET01847 | DBMET01847 | |
| 0.099 | 0.039 | 0.099 | Carbonic anhydrase XIII inhibitor | 0.08 0.05 DBMET01846 0.095 0.04 DBMET01847 | ||
| 0.098 | 0.038 | 0.099 | Inducible nitric-oxide synthase inhibitor | 0.082 0.058 DBMET01845 0.099 0.038 DBMET01846 0.091 0.046 DBMET01847 | DBMET01846 | |
| 0.077 | 0.018 | 0.087 | Sphingosine kinase inhibitor | 0.062 0.036 DBMET01845 0.07 0.025 DBMET01846 0.087 0.012 DBMET01847 | DBMET01847 | |
| 0.106 | 0.047 | 0.133 | Uric acid excretion stimulant | 0.123 0.036 DBMET01845 0.133 0.031 DBMET01846 | DBMET01846 | |
| 0.119 | 0.061 | 0.119 | Caspase 3 inhibitor | 0.115 0.068 DBMET01845 0.113 0.07 DBMET01846 | ||
| 0.142 | 0.084 | 0.142 | Diuretic | 0.141 0.084 DBMET01846 | ||
| 0.065 | 0.008 | 0.066 | Guanylate cyclase inhibitor | 0.064 0.008 DBMET01845 0.066 0.007 DBMET01846 0.059 0.013 DBMET01847 | DBMET01846 | |
| 0.061 | 0.004 | 0.064 | Retinoid X alpha receptor antagonist | 0.064 0.003 DBMET01845 0.06 0.004 DBMET01846 0.051 0.005 DBMET01847 | DBMET01845 | |
| 0.069 | 0.012 | 0.085 | Adenylate cyclase 1 inhibitor | 0.058 0.019 DBMET01845 0.057 0.02 DBMET01846 0.085 0.006 DBMET01847 | DBMET01847 | |
| 0.106 | 0.05 | 0.124 | Electrolyte absorption antagonist | 0.101 0.057 DBMET01845 0.107 0.048 DBMET01846 0.124 0.033 DBMET01847 | DBMET01847 | |
| 0.164 | 0.108 | 0.164 | Interleukin antagonist | 0.147 0.12 DBMET01845 0.157 0.113 DBMET01846 | ||
| 0.06 | 0.005 | 0.06 | ATP citrate lysase inhibitor | 0.055 0.006 DBMET01845 0.059 0.005 DBMET01846 0.038 0.014 DBMET01847 | ||
| 0.088 | 0.033 | 0.093 | Sphingosine 1-phosphate receptor antagonist | 0.092 0.028 DBMET01845 0.093 0.027 DBMET01846 | DBMET01846 | |
| 0.081 | 0.027 | 0.081 | Glutamate (mGluR7) antagonist | 0.078 0.03 DBMET01845 0.073 0.038 DBMET01846 0.062 0.059 DBMET01847 | ||
| 0.105 | 0.051 | 0.156 | DNA directed RNA polymerase inhibitor | 0.143 0.026 DBMET01845 0.156 0.022 DBMET01846 | DBMET01846 | |
| 0.121 | 0.067 | 0.148 | Alkylator | 0.148 0.048 DBMET01845 0.143 0.05 DBMET01846 | DBMET01845 | |
| 0.095 | 0.042 | 0.103 | Granulocyte macrophage colony stimulating factor agonist | 0.103 0.032 DBMET01845 0.097 0.039 DBMET01846 0.085 0.062 DBMET01847 | DBMET01845 | |
| 0.061 | 0.008 | 0.07 | Purinergic P2X3 antagonist | 0.067 0.007 DBMET01845 0.07 0.006 DBMET01846 | DBMET01846 | |
| 0.091 | 0.037 | 0.096 | Cathepsin G inhibitor | 0.096 0.035 DBMET01845 0.092 0.036 DBMET01846 | DBMET01845 | |
| 0.068 | 0.015 | 0.068 | Leukocyte elastase inhibitor | 0.054 0.021 DBMET01845 0.065 0.016 DBMET01846 | ||
| 0.093 | 0.04 | 0.154 | CYP2A6 inhibitor | 0.097 0.037 DBMET01845 0.09 0.041 DBMET01846 0.154 0.015 DBMET01847 | DBMET01847 | |
| 0.056 | 0.003 | 0.056 | Estrogen-related receptor gamma antagonist | 0.045 0.004 DBMET01845 0.048 0.004 DBMET01846 0.039 0.005 DBMET01847 | ||
| 0.075 | 0.023 | 0.075 | Cyclin D1 inhibitor | 0.063 0.038 DBMET01845 0.071 0.027 DBMET01846 | ||
| 0.075 | 0.023 | 0.1 | Transcription factor RelA inhibitor | 0.063 0.044 DBMET01845 0.069 0.031 DBMET01846 0.1 0.006 DBMET01847 | DBMET01847 | |
| 0.068 | 0.016 | 0.083 | Estradiol 17 beta-dehydrogenase inhibitor | 0.057 0.021 DBMET01845 0.083 0.013 DBMET01846 0.043 0.029 DBMET01847 | DBMET01846 | |
| 0.067 | 0.016 | 0.067 | Squalene epoxidase inhibitor | 0.056 0.024 DBMET01845 0.061 0.019 DBMET01846 0.049 0.035 DBMET01847 | ||
| 0.068 | 0.017 | 0.068 | Adenine nucleotide translocase inhibitor | 0.057 0.035 DBMET01845 0.057 0.034 DBMET01846 0.062 0.025 DBMET01847 | ||
| 0.15 | 0.1 | 0.15 | Tumour necrosis factor antagonist | 0.142 0.111 DBMET01846 | ||
| 0.055 | 0.005 | 0.066 | Cholesterol ester transfer protein antagonist | 0.066 0.004 DBMET01845 0.059 0.005 DBMET01846 0.036 0.016 DBMET01847 | DBMET01845 | |
| 0.101 | 0.052 | 0.107 | Alcohol dehydrogenase inhibitor | 0.107 0.046 DBMET01845 0.097 0.056 DBMET01846 | DBMET01845 | |
| 0.075 | 0.027 | 0.075 | MDM2 inhibitor | 0.069 0.041 DBMET01845 0.074 0.029 DBMET01846 | ||
| 0.068 | 0.02 | 0.069 | Acetyl-CoA transferase 2 inhibitor | 0.064 0.025 DBMET01845 0.069 0.018 DBMET01846 | DBMET01846 | |
| 0.073 | 0.026 | 0.073 | Phosphodiesterase 1C inhibitor | 0.062 0.043 DBMET01845 0.067 0.033 DBMET01846 | ||
| 0.083 | 0.036 | 0.101 | HIV-1 integrase inhibitor | 0.101 0.024 DBMET01845 0.078 0.04 DBMET01846 0.08 0.038 DBMET01847 | DBMET01845 | |
| 0.053 | 0.006 | 0.053 | Sodium/glucose cotransporter 2 inhibitor | 0.037 0.009 DBMET01845 0.047 0.007 DBMET01846 0.044 0.008 DBMET01847 | ||
| 0.105 | 0.058 | 0.105 | Bronchodilator | 0.104 0.059 DBMET01846 | ||
| 0.103 | 0.056 | 0.103 | Nitric-oxide synthase inhibitor | 0.098 0.063 DBMET01846 | ||
| 0.068 | 0.022 | 0.068 | Glycine transporter 2 inhibitor | 0.041 0.038 DBMET01845 0.049 0.031 DBMET01846 | ||
| 0.074 | 0.029 | 0.074 | NMDA 2C receptor antagonist | 0.068 0.035 DBMET01845 0.062 0.042 DBMET01846 | ||
| 0.068 | 0.023 | 0.075 | Peroxisome proliferator-activated receptor alpha agonist | 0.066 0.024 DBMET01845 0.075 0.02 DBMET01846 | DBMET01846 | |
| 0.05 | 0.005 | 0.053 | Glutamate (mGluR3) agonist | 0.047 0.005 DBMET01845 0.053 0.004 DBMET01846 0.036 0.014 DBMET01847 | DBMET01846 | |
| 0.069 | 0.025 | 0.069 | NMDA 2A receptor antagonist | 0.053 0.035 DBMET01845 0.059 0.03 DBMET01846 | ||
| 0.058 | 0.014 | 0.058 | Liver X receptor alpha agonist | 0.045 0.023 DBMET01845 0.054 0.017 DBMET01846 | ||
| 0.06 | 0.016 | 0.061 | 5-Alpha-reductase inhibitor | 0.061 0.015 DBMET01845 0.053 0.017 DBMET01846 0.046 0.02 DBMET01847 | DBMET01845 | |
| 0.149 | 0.105 | 0.159 | DNA methyltransferase I inhibitor | 0.159 0.095 DBMET01845 0.158 0.096 DBMET01846 | DBMET01845 | |
| 0.052 | 0.008 | 0.055 | Free fatty acid receptor 1 antagonist | 0.053 0.008 DBMET01845 0.055 0.007 DBMET01846 | DBMET01846 | |
| 0.089 | 0.046 | 0.091 | Adrenaline agonist | 0.091 0.045 DBMET01846 0.088 0.047 DBMET01847 | DBMET01846 | |
| 0.072 | 0.029 | 0.084 | Argininosuccinate synthase inhibitor | 0.084 0.024 DBMET01845 0.076 0.027 DBMET01846 0.053 0.044 DBMET01847 | DBMET01845 | |
| 0.121 | 0.078 | 0.134 | Cyclooxygenase 2 inhibitor | 0.134 0.066 DBMET01845 0.131 0.069 DBMET01846 | DBMET01845 | |
| 0.082 | 0.04 | 0.086 | MAP kinase kinase 7 inhibitor | 0.084 0.035 DBMET01845 0.08 0.045 DBMET01846 0.086 0.031 DBMET01847 | DBMET01847 | |
| 0.07 | 0.028 | 0.07 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.057 0.051 DBMET01845 0.07 0.027 DBMET01846 | ||
| 0.055 | 0.012 | 0.076 | Estrogen-related receptor alpha antagonist | 0.052 0.013 DBMET01845 0.076 0.009 DBMET01846 | DBMET01846 | |
| 0.068 | 0.025 | 0.068 | Alpha tubulin antagonist | 0.053 0.037 DBMET01845 0.068 0.025 DBMET01846 | ||
| 0.118 | 0.076 | 0.31 | MAO inhibitor | 0.31 0.019 DBMET01847 | DBMET01847 | |
| 0.1 | 0.058 | 0.1 | Interleukin 1 beta converting enzyme inhibitor | 0.1 0.058 DBMET01845 0.1 0.058 DBMET01846 | ||
| 0.059 | 0.018 | 0.062 | Oxytocin agonist | 0.062 0.015 DBMET01845 0.06 0.017 DBMET01846 | DBMET01845 | |
| 0.24 | 0.199 | 0.254 | DNA polymerase beta inhibitor | 0.243 0.197 DBMET01845 0.254 0.19 DBMET01847 | DBMET01847 | |
| 0.066 | 0.024 | 0.078 | Dihydroorotate dehydrogenase inhibitor | 0.078 0.019 DBMET01845 0.059 0.029 DBMET01846 0.072 0.021 DBMET01847 | DBMET01845 | |
| 0.06 | 0.019 | 0.064 | Glucose-6-phosphate isomerase inhibitor | 0.064 0.015 DBMET01845 0.064 0.016 DBMET01846 0.054 0.025 DBMET01847 | DBMET01846 | |
| 0.045 | 0.004 | 0.131 | Retinoid X gamma receptor antagonist | 0.045 0.004 DBMET01845 0.045 0.004 DBMET01846 0.131 0.001 DBMET01847 | DBMET01847 | |
| 0.064 | 0.023 | 0.071 | Aconitate hydratase inhibitor | 0.071 0.018 DBMET01845 0.064 0.023 DBMET01846 0.05 0.039 DBMET01847 | DBMET01845 | |
| 0.067 | 0.026 | 0.067 | Beta 2 adrenoreceptor agonist | 0.062 0.042 DBMET01845 0.066 0.028 DBMET01846 | ||
| 0.118 | 0.077 | 0.118 | Cathepsin H inhibitor | 0.114 0.084 DBMET01845 | ||
| 0.049 | 0.008 | 0.052 | HMG CoA reductase inhibitor | 0.052 0.006 DBMET01845 0.052 0.006 DBMET01846 | DBMET01846 | |
| 0.132 | 0.092 | 0.186 | Hemostatic | 0.186 0.039 DBMET01845 0.156 0.061 DBMET01846 | DBMET01845 | |
| 0.045 | 0.004 | 0.187 | Retinoic acid alpha receptor antagonist | 0.038 0.005 DBMET01845 0.045 0.004 DBMET01846 0.187 0.002 DBMET01847 | DBMET01847 | |
| 0.045 | 0.006 | 0.045 | Sodium/glucose cotransporter inhibitor | 0.033 0.009 DBMET01845 0.04 0.007 DBMET01846 0.031 0.01 DBMET01847 | ||
| 0.154 | 0.115 | 0.223 | I kappa B kinase epsilon inhibitor | 0.141 0.13 DBMET01846 0.223 0.054 DBMET01847 | DBMET01847 | |
| 0.075 | 0.036 | 0.075 | Leukotriene antagonist | 0.06 0.051 DBMET01845 0.072 0.039 DBMET01846 0.068 0.041 DBMET01847 | ||
| 0.043 | 0.004 | 0.064 | Vanilloid 2 agonist | 0.04 0.004 DBMET01845 0.045 0.003 DBMET01846 0.064 0.002 DBMET01847 | DBMET01847 | |
| 0.042 | 0.003 | 0.042 | Retinoid X beta receptor antagonist | 0.04 0.003 DBMET01845 0.039 0.003 DBMET01846 0.034 0.004 DBMET01847 | ||
| 0.087 | 0.049 | 0.087 | Carbonic anhydrase VI inhibitor | 0.074 0.065 DBMET01846 | ||
| 0.079 | 0.041 | 0.154 | Peroxisome proliferator-activated receptor gamma agonist | 0.089 0.034 DBMET01845 0.103 0.026 DBMET01846 0.154 0.012 DBMET01847 | DBMET01847 | |
| 0.042 | 0.004 | 0.298 | Retinoic acid receptor antagonist | 0.036 0.005 DBMET01845 0.042 0.004 DBMET01846 0.298 0.002 DBMET01847 | DBMET01847 | |
| 0.071 | 0.033 | 0.071 | Aromatase inhibitor | 0.062 0.04 DBMET01845 0.071 0.033 DBMET01846 0.06 0.042 DBMET01847 | ||
| 0.126 | 0.088 | 0.133 | CC chemokine 6 receptor antagonist | 0.133 0.059 DBMET01845 | DBMET01845 | |
| 0.07 | 0.032 | 0.076 | Bombesin 1 receptor agonist | 0.076 0.027 DBMET01845 0.07 0.032 DBMET01846 | DBMET01845 | |
| 0.098 | 0.061 | 0.168 | Xanthine oxidase inhibitor | 0.092 0.068 DBMET01845 0.104 0.057 DBMET01846 0.168 0.028 DBMET01847 | DBMET01847 | |
| 0.047 | 0.009 | 0.047 | Liver X receptor beta antagonist | 0.037 0.014 DBMET01845 0.046 0.01 DBMET01846 | ||
| 0.072 | 0.035 | 0.079 | Beta adrenoreceptor antagonist | 0.072 0.035 DBMET01845 0.079 0.028 DBMET01846 | DBMET01846 | |
| 0.07 | 0.034 | 0.071 | Beta 3 adrenoreceptor antagonist | 0.069 0.035 DBMET01845 0.071 0.033 DBMET01846 | DBMET01846 | |
| 0.236 | 0.2 | 0.267 | DNA directed DNA polymerase inhibitor | 0.238 0.199 DBMET01845 0.267 0.181 DBMET01847 | DBMET01847 | |
| 0.118 | 0.082 | 0.195 | Tubulin antagonist | 0.113 0.087 DBMET01846 0.195 0.038 DBMET01847 | DBMET01847 | |
| 0.047 | 0.011 | 0.064 | Vanilloid 3 antagonist | 0.064 0.004 DBMET01845 0.046 0.012 DBMET01846 | DBMET01845 | |
| 0.058 | 0.024 | 0.06 | CXC chemokine 1 receptor antagonist | 0.06 0.021 DBMET01845 0.056 0.027 DBMET01846 | DBMET01845 | |
| 0.038 | 0.003 | 0.038 | Estrogen-related receptor gamma agonist | 0.031 0.004 DBMET01845 0.036 0.003 DBMET01846 0.022 0.008 DBMET01847 | ||
| 0.051 | 0.017 | 0.051 | Dihydrofolate reductase inhibitor | 0.047 0.024 DBMET01845 0.049 0.02 DBMET01846 0.048 0.022 DBMET01847 | ||
| 0.064 | 0.03 | 0.084 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.072 0.025 DBMET01845 0.072 0.025 DBMET01846 0.084 0.019 DBMET01847 | DBMET01847 | |
| 0.039 | 0.005 | 0.041 | Imidazoline I1 receptor antagonist | 0.041 0.005 DBMET01845 0.039 0.005 DBMET01846 | DBMET01845 | |
| 0.065 | 0.031 | 0.073 | Sphingosine 1-phosphate receptor 3 antagonist | 0.073 0.022 DBMET01845 0.069 0.026 DBMET01846 | DBMET01845 | |
| 0.05 | 0.016 | 0.051 | Sphingosine kinase 1 inhibitor | 0.04 0.031 DBMET01845 0.045 0.023 DBMET01846 0.051 0.015 DBMET01847 | DBMET01847 | |
| 0.065 | 0.032 | 0.072 | Maillard reaction inhibitor | 0.067 0.031 DBMET01846 0.072 0.028 DBMET01847 | DBMET01847 | |
| 0.086 | 0.053 | 0.112 | Antineoplastic antibiotic | 0.101 0.046 DBMET01845 0.102 0.046 DBMET01846 0.112 0.041 DBMET01847 | DBMET01847 | |
| 0.089 | 0.056 | 0.108 | Calcium antagonist | 0.1 0.048 DBMET01845 0.108 0.042 DBMET01846 | DBMET01846 | |
| 0.12 | 0.088 | 0.128 | Interleukin 1 antagonist | 0.113 0.1 DBMET01845 0.128 0.078 DBMET01846 | DBMET01846 | |
| 0.099 | 0.067 | 0.122 | Nav1.1 sodium channel blocker | 0.122 0.047 DBMET01845 0.114 0.052 DBMET01846 | DBMET01845 | |
| 0.037 | 0.005 | 0.037 | Calcium-sensing receptor antagonist | 0.032 0.006 DBMET01845 0.029 0.006 DBMET01846 | ||
| 0.094 | 0.063 | 0.187 | MAO B inhibitor | 0.187 0.027 DBMET01847 | DBMET01847 | |
| 0.129 | 0.098 | 0.129 | Insulin secretagoues | |||
| 0.052 | 0.022 | 0.052 | Purinergic P2X4 antagonist | 0.045 0.032 DBMET01845 0.046 0.031 DBMET01846 | ||
| 0.044 | 0.014 | 0.046 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.043 0.014 DBMET01845 0.046 0.013 DBMET01846 0.029 0.026 DBMET01847 | DBMET01846 | |
| 0.124 | 0.094 | 0.139 | Cell wall synthesis inhibitor | 0.139 0.076 DBMET01845 0.128 0.089 DBMET01846 0.113 0.111 DBMET01847 | DBMET01845 | |
| 0.047 | 0.017 | 0.061 | Farnesoid X receptor agonist | 0.054 0.012 DBMET01845 0.061 0.01 DBMET01846 | DBMET01846 | |
| 0.045 | 0.016 | 0.046 | Glutamate (mGluR8) agonist | 0.042 0.019 DBMET01845 0.046 0.014 DBMET01846 0.041 0.021 DBMET01847 | DBMET01846 | |
| 0.046 | 0.017 | 0.046 | Nicotinic acid receptor agonist | 0.046 0.016 DBMET01845 0.044 0.018 DBMET01846 | ||
| 0.034 | 0.005 | 0.034 | ICAM 1 antagonist | 0.026 0.01 DBMET01845 0.029 0.007 DBMET01846 | ||
| 0.061 | 0.032 | 0.075 | Acyl-CoA dehydrogenase inhibitor | 0.07 0.027 DBMET01845 0.064 0.03 DBMET01846 0.075 0.024 DBMET01847 | DBMET01847 | |
| 0.047 | 0.019 | 0.047 | Alpha 1d adrenoreceptor agonist | 0.037 0.03 DBMET01845 0.043 0.023 DBMET01846 | ||
| 0.053 | 0.025 | 0.073 | Dopamine beta hydroxylase inhibitor | 0.057 0.019 DBMET01845 0.055 0.021 DBMET01846 0.073 0.007 DBMET01847 | DBMET01847 | |
| 0.089 | 0.062 | 0.089 | Potassium channel activator | 0.082 0.072 DBMET01846 0.086 0.066 DBMET01847 | ||
| 0.04 | 0.014 | 0.089 | Catechol O-methyltransferase inhibitor | 0.089 0.005 DBMET01845 0.042 0.013 DBMET01846 | DBMET01845 | |
| 0.065 | 0.039 | 0.073 | Carbamoyl phosphate synthetase inhibitor | 0.073 0.032 DBMET01845 0.073 0.032 DBMET01846 0.057 0.046 DBMET01847 | DBMET01846 | |
| 0.055 | 0.029 | 0.058 | Beta 2 adrenoreceptor antagonist | 0.057 0.027 DBMET01845 0.058 0.026 DBMET01846 | DBMET01846 | |
| 0.071 | 0.045 | 0.075 | Toll-Like receptor 7 antagonist | 0.075 0.042 DBMET01845 0.068 0.048 DBMET01846 | DBMET01845 | |
| 0.058 | 0.032 | 0.058 | DNA helicase inhibitor | 0.051 0.046 DBMET01846 | ||
| 0.043 | 0.018 | 0.043 | Glutamate (mGluR3) antagonist | 0.033 0.032 DBMET01845 0.037 0.025 DBMET01846 | ||
| 0.075 | 0.051 | 0.098 | Vanilloid 4 agonist | 0.087 0.03 DBMET01845 0.087 0.03 DBMET01846 0.098 0.018 DBMET01847 | DBMET01847 | |
| 0.049 | 0.024 | 0.056 | Parathyroid hormone antagonist | 0.056 0.015 DBMET01845 0.056 0.014 DBMET01846 | DBMET01846 | |
| 0.098 | 0.073 | 0.102 | AMP-activated protein kinase stimulant | 0.093 0.08 DBMET01845 0.102 0.067 DBMET01846 | DBMET01846 | |
| 0.035 | 0.01 | 0.048 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.024 0.015 DBMET01845 0.048 0.007 DBMET01846 0.022 0.016 DBMET01847 | DBMET01846 | |
| 0.095 | 0.071 | 0.095 | Glutamate (mGluR7) agonist | 0.091 0.081 DBMET01845 0.093 0.075 DBMET01846 | ||
| 0.043 | 0.019 | 0.064 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.038 0.023 DBMET01845 0.064 0.01 DBMET01846 | DBMET01846 | |
| 0.066 | 0.043 | 0.07 | Aryl hydrocarbon receptor antagonist | 0.067 0.041 DBMET01845 0.069 0.038 DBMET01846 0.07 0.038 DBMET01847 | DBMET01847 | |
| 0.037 | 0.013 | 0.041 | Uridine phosphorylase inhibitor | 0.025 0.022 DBMET01845 0.029 0.019 DBMET01846 0.041 0.011 DBMET01847 | DBMET01847 | |
| 0.033 | 0.01 | 0.035 | Nicotinic acid receptor 2 antagonist | 0.035 0.007 DBMET01845 0.032 0.01 DBMET01846 | DBMET01845 | |
| 0.068 | 0.046 | 0.068 | Leukotriene synthesis inhibitor | 0.068 0.046 DBMET01846 | ||
| 0.074 | 0.051 | 0.075 | Potassium channel (Tandem pore domain) blocker | 0.075 0.048 DBMET01845 0.071 0.06 DBMET01846 | DBMET01845 | |
| 0.033 | 0.011 | 0.037 | Peroxisome proliferator-activated receptor alpha antagonist | 0.022 0.015 DBMET01845 0.037 0.01 DBMET01846 | DBMET01846 | |
| 0.095 | 0.074 | 0.095 | Folate antagonist | 0.094 0.077 DBMET01845 0.095 0.075 DBMET01846 | ||
| 0.073 | 0.051 | 0.073 | Lipase inhibitor | 0.068 0.057 DBMET01846 | ||
| 0.103 | 0.081 | 0.103 | Acetylcholine release stimulant | 0.098 0.093 DBMET01846 | ||
| 0.036 | 0.016 | 0.036 | Glucagon receptor antagonist | 0.029 0.021 DBMET01846 | ||
| 0.03 | 0.009 | 0.03 | Glutamate (mGluR1a) agonist | 0.022 0.015 DBMET01845 0.022 0.016 DBMET01846 | ||
| 0.09 | 0.069 | 0.099 | Toll-Like receptor 3 antagonist | 0.099 0.052 DBMET01845 | DBMET01845 | |
| 0.06 | 0.04 | 0.06 | Beta tubulin antagonist | 0.057 0.042 DBMET01846 | ||
| 0.133 | 0.113 | 0.133 | Dual specificity phosphatase 3 inhibitor | |||
| 0.092 | 0.071 | 0.103 | Phosphodiesterase 6D inhibitor | 0.103 0.046 DBMET01847 | DBMET01847 | |
| 0.059 | 0.039 | 0.059 | Xanthine dehydrogenase inhibitor | 0.05 0.046 DBMET01845 0.058 0.04 DBMET01846 0.051 0.045 DBMET01847 | ||
| 0.038 | 0.019 | 0.045 | Peroxisome proliferator-activated receptor delta agonist | 0.045 0.014 DBMET01845 0.045 0.014 DBMET01846 | DBMET01846 | |
| 0.031 | 0.013 | 0.031 | CXC chemokine 2 receptor antagonist | 0.03 0.014 DBMET01845 0.031 0.013 DBMET01846 | ||
| 0.047 | 0.029 | 0.047 | Fructose-1,6-bisphosphatase inhibitor | 0.04 0.039 DBMET01845 0.044 0.032 DBMET01846 | ||
| 0.03 | 0.013 | 0.031 | Hedgehog signaling activator | 0.031 0.012 DBMET01845 0.031 0.012 DBMET01846 | DBMET01846 | |
| 0.028 | 0.01 | 0.051 | Dopamine D1 agonist | 0.05 0.005 DBMET01845 0.051 0.005 DBMET01846 0.032 0.008 DBMET01847 | DBMET01846 | |
| 0.027 | 0.01 | 0.027 | Protease (Human cytomegalovirus) inhibitor | 0.025 0.011 DBMET01845 0.022 0.015 DBMET01846 | ||
| 0.043 | 0.026 | 0.061 | Kainate receptor agonist | 0.046 0.019 DBMET01845 0.043 0.024 DBMET01846 0.061 0.006 DBMET01847 | DBMET01847 | |
| 0.052 | 0.036 | 0.062 | Vanilloid 2 antagonist | 0.051 0.038 DBMET01846 0.062 0.021 DBMET01847 | DBMET01847 | |
| 0.07 | 0.054 | 0.07 | Phospholipase D inhibitor | 0.07 0.054 DBMET01845 | ||
| 0.067 | 0.051 | 0.107 | HIV-1 reverse transcriptase inhibitor | 0.102 0.03 DBMET01845 0.107 0.027 DBMET01846 | DBMET01846 | |
| 0.056 | 0.041 | 0.058 | Leukotriene C antagonist | 0.054 0.049 DBMET01845 0.056 0.039 DBMET01846 0.058 0.033 DBMET01847 | DBMET01847 | |
| 0.044 | 0.029 | 0.044 | Glutamate (mGluR group III) antagonist | 0.041 0.038 DBMET01847 | ||
| 0.02 | 0.004 | 0.135 | Retinoic acid beta receptor antagonist | 0.017 0.005 DBMET01845 0.02 0.004 DBMET01846 0.135 0.002 DBMET01847 | DBMET01847 | |
| 0.058 | 0.043 | 0.058 | Carbonic anhydrase stimulant | 0.052 0.051 DBMET01845 0.055 0.047 DBMET01846 | ||
| 0.033 | 0.018 | 0.033 | Cyclophilin A inhibitor | 0.032 0.02 DBMET01846 | ||
| 0.049 | 0.034 | 0.051 | Topoisomerase II beta inhibitor | 0.048 0.037 DBMET01845 0.051 0.032 DBMET01846 | DBMET01846 | |
| 0.05 | 0.036 | 0.05 | CD45 antagonist | 0.047 0.043 DBMET01846 | ||
| 0.04 | 0.026 | 0.04 | CF transmembrane conductance regulator antagonist | 0.038 0.036 DBMET01846 0.039 0.031 DBMET01847 | ||
| 0.052 | 0.039 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.055 | 0.041 | 0.063 | Beta 1 adrenoreceptor antagonist | 0.054 0.042 DBMET01845 0.063 0.032 DBMET01846 | DBMET01846 | |
| 0.079 | 0.065 | 0.079 | Thioredoxin reductase inhibitor | 0.078 0.068 DBMET01845 0.078 0.068 DBMET01846 | ||
| 0.067 | 0.054 | 0.067 | NMDA 2 receptor antagonist | |||
| 0.052 | 0.039 | 0.052 | Toll-Like receptor 8 antagonist | 0.05 0.042 DBMET01846 | ||
| 0.032 | 0.018 | 0.032 | Complement C5a chemotactic receptor antagonist | 0.03 0.021 DBMET01845 0.032 0.018 DBMET01846 | ||
| 0.09 | 0.077 | 0.115 | GABA C receptor rho-1 antagonist | 0.102 0.06 DBMET01845 0.101 0.061 DBMET01846 0.115 0.044 DBMET01847 | DBMET01847 | |
| 0.069 | 0.056 | 0.074 | Catalase inhibitor | 0.069 0.055 DBMET01845 0.074 0.052 DBMET01846 | DBMET01846 | |
| 0.131 | 0.118 | 0.131 | Dual specificity phosphatase inhibitor | |||
| 0.021 | 0.008 | 0.024 | Nicotinic acid receptor 1 antagonist | 0.024 0.005 DBMET01845 0.021 0.008 DBMET01846 | DBMET01845 | |
| 0.052 | 0.039 | 0.053 | Alpha-mannosidase inhibitor | 0.051 0.043 DBMET01845 0.053 0.037 DBMET01846 | DBMET01846 | |
| 0.023 | 0.01 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.009 DBMET01845 0.023 0.01 DBMET01846 | ||
| 0.034 | 0.021 | 0.034 | Liver X receptor beta agonist | 0.03 0.029 DBMET01846 | ||
| 0.022 | 0.01 | 0.023 | Progesterone receptor B antagonist | 0.023 0.009 DBMET01846 0.021 0.01 DBMET01847 | DBMET01846 | |
| 0.017 | 0.005 | 0.161 | Retinoic acid receptor gamma antagonist | 0.014 0.005 DBMET01845 0.017 0.005 DBMET01846 0.161 0.002 DBMET01847 | DBMET01847 | |
| 0.027 | 0.015 | 0.027 | Prostaglandin H2 antagonist | 0.024 0.019 DBMET01845 0.024 0.019 DBMET01846 | ||
| 0.02 | 0.008 | 0.021 | Telomerase stimulant | 0.021 0.007 DBMET01845 0.021 0.007 DBMET01846 0.016 0.014 DBMET01847 | DBMET01846 | |
| 0.05 | 0.04 | 0.05 | Ribonucleoside-diphosphate reductase inhibitor | 0.049 0.041 DBMET01845 0.049 0.042 DBMET01846 | ||
| 0.015 | 0.005 | 0.018 | Imidazoline I2 receptor antagonist | 0.018 0.004 DBMET01845 0.015 0.005 DBMET01846 | DBMET01845 | |
| 0.023 | 0.013 | 0.028 | Vitamin D receptor antagonist | 0.028 0.008 DBMET01845 0.028 0.008 DBMET01846 | DBMET01846 | |
| 0.112 | 0.102 | 0.112 | Histone deacetylase SIRT1 inhibitor | |||
| 0.02 | 0.011 | 0.021 | Antibiotic Anthracycline-like | 0.02 0.012 DBMET01845 0.021 0.01 DBMET01846 0.019 0.014 DBMET01847 | DBMET01846 | |
| 0.021 | 0.012 | 0.021 | 5-Alpha-reductase 2 inhibitor | 0.018 0.015 DBMET01845 0.019 0.014 DBMET01846 | ||
| 0.025 | 0.016 | 0.036 | Glutamate (mGluR1) agonist | 0.036 0.006 DBMET01847 | DBMET01847 | |
| 0.013 | 0.004 | 0.013 | Progesterone receptor A antagonist | 0.01 0.005 DBMET01846 0.012 0.005 DBMET01847 | ||
| 0.015 | 0.007 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.014 0.008 DBMET01845 0.013 0.01 DBMET01846 | ||
| 0.031 | 0.023 | 0.036 | Glucocorticoid antagonist | 0.028 0.025 DBMET01845 0.036 0.021 DBMET01846 | DBMET01846 | |
| 0.053 | 0.045 | 0.063 | Fatty acid synthase inhibitor | 0.062 0.033 DBMET01845 0.063 0.032 DBMET01846 | DBMET01846 | |
| 0.023 | 0.015 | 0.024 | Prostaglandin F2 alpha agonist | 0.024 0.014 DBMET01846 0.021 0.019 DBMET01847 | DBMET01846 | |
| 0.14 | 0.132 | 0.14 | Death-associated protein kinase 2 inhibitor | |||
| 0.091 | 0.084 | 0.098 | mTOR complex 1 inhibitor | 0.098 0.066 DBMET01845 0.097 0.068 DBMET01846 | DBMET01845 | |
| 0.051 | 0.044 | 0.051 | GABA receptor antagonist | |||
| 0.049 | 0.043 | 0.051 | Ribonucleotide reductase inhibitor | 0.051 0.042 DBMET01845 0.048 0.044 DBMET01846 | DBMET01845 | |
| 0.019 | 0.012 | 0.037 | Alpha 2b adrenoreceptor agonist | 0.023 0.007 DBMET01845 0.021 0.009 DBMET01846 0.037 0.004 DBMET01847 | DBMET01847 | |
| 0.05 | 0.044 | 0.064 | Leukotriene B4 antagonist | 0.049 0.046 DBMET01846 0.064 0.024 DBMET01847 | DBMET01847 | |
| 0.083 | 0.077 | 0.329 | MAO A inhibitor | 0.329 0.013 DBMET01847 | DBMET01847 | |
| 0.04 | 0.034 | 0.044 | NMDA receptor subunit 3B antagonist | 0.044 0.031 DBMET01845 0.04 0.035 DBMET01846 | DBMET01845 | |
| 0.05 | 0.044 | 0.05 | Heparanase inhibitor | |||
| 0.123 | 0.117 | 0.123 | Neuropeptide Y1 antagonist | |||
| 0.028 | 0.022 | 0.03 | Liver X receptor alpha antagonist | 0.03 0.019 DBMET01846 | DBMET01846 | |
| 0.033 | 0.027 | 0.053 | Tubulin agonist | 0.053 0.007 DBMET01847 | DBMET01847 | |
| 0.038 | 0.033 | 0.04 | Thymidine kinase inhibitor | 0.04 0.03 DBMET01845 0.038 0.033 DBMET01846 | DBMET01845 | |
| 0.022 | 0.017 | 0.022 | CYP24 inhibitor | |||
| 0.032 | 0.027 | 0.036 | Fumarate hydratase inhibitor | 0.036 0.022 DBMET01845 0.035 0.023 DBMET01846 | DBMET01845 | |
| 0.029 | 0.024 | 0.03 | Liver X receptor antagonist | 0.03 0.023 DBMET01846 | DBMET01846 | |
| 0.064 | 0.06 | 0.069 | Protein kinase C beta inhibitor | 0.069 0.049 DBMET01846 | DBMET01846 | |
| 0.036 | 0.032 | 0.036 | Dihydropteroate synthase inhibitor | 0.036 0.033 DBMET01847 | ||
| 0.033 | 0.029 | 0.051 | Adenosine uptake inhibitor | 0.051 0.004 DBMET01847 | DBMET01847 | |
| 0.043 | 0.04 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.038 DBMET01846 | DBMET01846 | |
| 0.031 | 0.028 | 0.033 | Progesterone antagonist | 0.033 0.026 DBMET01847 | DBMET01847 | |
| 0.031 | 0.028 | 0.031 | Purinergic P2Y2 antagonist | |||
| 0.04 | 0.037 | 0.041 | AICAR transformylase inhibitor | 0.041 0.036 DBMET01845 | DBMET01845 | |
| 0.016 | 0.013 | 0.019 | Vitamin D receptor agonist | 0.019 0.007 DBMET01845 0.018 0.008 DBMET01846 | DBMET01845 | |
| 0.059 | 0.056 | 0.085 | Interferon inducer | 0.085 0.02 DBMET01845 0.069 0.037 DBMET01846 | DBMET01845 | |
| 0.03 | 0.028 | 0.037 | Estrogen-related receptor beta antagonist | 0.037 0.015 DBMET01847 | DBMET01847 | |
| 0.01 | 0.008 | 0.012 | Thromboxane agonist | 0.011 0.007 DBMET01845 0.012 0.006 DBMET01846 | DBMET01846 | |
| 0.05 | 0.048 | 0.05 | Plasminogen activator inhibitor | |||
| 0.028 | 0.026 | 0.028 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.093 | 0.091 | 0.097 | Protein kinase C gamma inhibitor | 0.097 0.083 DBMET01846 | DBMET01846 | |
| 0.022 | 0.02 | 0.022 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.022 0.02 DBMET01846 | ||
| 0.047 | 0.045 | 0.047 | GABA A receptor antagonist | |||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | |||
| 0.012 | 0.011 | 0.012 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.018 | 0.017 | 0.018 | Caspase 8 inhibitor | 0.018 0.016 DBMET01846 | ||
| 0.055 | 0.054 | 0.055 | Transcription factor AP-1 inhibitor | |||
| 0.013 | 0.013 | 0.014 | Egl nine homolog 1 inhibitor | 0.014 0.012 DBMET01846 | DBMET01846 | |
| 0.031 | 0.03 | 0.031 | Phosphoglycerate kinase inhibitor | |||
| 0.008 | 0.009 | 0.009 | Corticotropin releasing factor antagonist | 0.009 0.007 DBMET01846 0.009 0.008 DBMET01847 | DBMET01847 | |
| 0.019 | 0.02 | 0.02 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 DBMET01845 0.02 0.019 DBMET01846 | DBMET01846 | |
| 0.036 | 0.037 | 0.038 | Leukotriene C4 antagonist | 0.038 0.03 DBMET01847 | DBMET01847 | |
| 0.049 | 0.052 | 0.052 | Thromboxane synthase inhibitor | 0.052 0.043 DBMET01845 | DBMET01845 | |
| 0.051 | 0.056 | 0.054 | Immunoglobulin Fc receptor antagonist | 0.054 0.041 DBMET01845 | DBMET01845 | |
| 0.034 | 0.039 | 0.184 | Retinoic acid alpha receptor agonist | 0.184 0.003 DBMET01847 | DBMET01847 | |
| 0.083 | 0.09 | 0.091 | Falcipain 3 inhibitor | 0.091 0.08 DBMET01845 | DBMET01845 | |
| 0.033 | 0.039 | 0.037 | Potassium channel Kv1.1 blocker | 0.037 0.029 DBMET01845 | DBMET01845 | |
| 0.033 | 0.04 | 0.038 | GABA uptake inhibitor | 0.038 0.03 DBMET01845 | DBMET01845 | |
| 0.025 | 0.032 | 0.031 | Lysophosphatidic acid 2 receptor antagonist | 0.028 0.026 DBMET01846 0.031 0.021 DBMET01847 | DBMET01847 | |
| 0.017 | 0.024 | 0.02 | Corticotropin releasing factor 1 receptor antagonist | 0.02 0.019 DBMET01846 | DBMET01846 | |
| 0.06 | 0.068 | 0.071 | Vanilloid antagonist | 0.071 0.055 DBMET01845 | DBMET01845 | |
| 0.068 | 0.076 | 0.099 | Interferon agonist | 0.099 0.029 DBMET01845 0.08 0.051 DBMET01846 | DBMET01845 | |
| 0.108 | 0.118 | 0.161 | Neurotrophic factor | 0.161 0.05 DBMET01845 | DBMET01845 | |
| 0.041 | 0.052 | 0.05 | Lysophosphatidic acid 3 receptor antagonist | 0.05 0.035 DBMET01847 | DBMET01847 | |
| 0.017 | 0.028 | 0.138 | Retinoid X gamma receptor agonist | 0.024 0.015 DBMET01845 0.138 0.003 DBMET01847 | DBMET01847 | |
| 0.036 | 0.049 | 0.05 | Cannabinoid CB2 receptor antagonist | 0.05 0.037 DBMET01847 | DBMET01847 | |
| 0.018 | 0.031 | 0.093 | Retinoic acid gamma receptor agonist | 0.093 0.002 DBMET01847 | DBMET01847 | |
| 0.064 | 0.077 | 0.071 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.071 0.057 DBMET01847 | DBMET01847 | |
| 0.126 | 0.14 | 0.207 | Psychostimulant | 0.14 0.126 DBMET01845 0.148 0.118 DBMET01846 0.207 0.076 DBMET01847 | DBMET01847 | |
| 0.033 | 0.047 | 0.042 | Sphingosine 1-phosphate receptor 1 agonist | 0.042 0.029 DBMET01845 0.042 0.03 DBMET01846 | DBMET01846 | |
| 0.017 | 0.032 | 0.131 | Retinoic acid receptor agonist | 0.131 0.003 DBMET01847 | DBMET01847 | |
| 0.072 | 0.088 | 0.146 | Ca(v)3.1 blocker | 0.079 0.065 DBMET01846 0.146 0.006 DBMET01847 | DBMET01847 | |
| 0.059 | 0.076 | 0.08 | Topoisomerase II alpha inhibitor | 0.08 0.053 DBMET01845 | DBMET01845 | |
| 0.059 | 0.078 | 0.08 | Exportin-1 inhibitor | 0.08 0.025 DBMET01847 | DBMET01847 | |
| 0.037 | 0.059 | 0.046 | Aldosterone antagonist | 0.046 0.035 DBMET01847 | DBMET01847 | |
| 0.012 | 0.035 | 0.025 | Alpha 2c adrenoreceptor agonist | 0.025 0.006 DBMET01847 | DBMET01847 | |
| 0.072 | 0.096 | 0.083 | Phosphodiesterase I inhibitor | 0.083 0.071 DBMET01845 | DBMET01845 | |
| 0.02 | 0.044 | 0.031 | Thymidine phosphorylase inhibitor | 0.031 0.011 DBMET01847 | DBMET01847 | |
| 0.073 | 0.097 | 0.092 | Bromodomain-containing protein 2 inhibitor | 0.092 0.052 DBMET01845 0.084 0.067 DBMET01846 | DBMET01845 | |
| 0.065 | 0.091 | 0.155 | Antineoplastic alkaloid | 0.077 0.069 DBMET01846 0.155 0.026 DBMET01847 | DBMET01847 | |
| 0.051 | 0.081 | 0.09 | Bcl-xL inhibitor | 0.09 0.008 DBMET01845 | DBMET01845 | |
| 0.043 | 0.075 | 0.084 | Alpha 2 adrenoreceptor agonist | 0.084 0.021 DBMET01847 | DBMET01847 | |
| 0.013 | 0.046 | 0.036 | Leukotriene B4 receptor 2 antagonist | 0.036 0.006 DBMET01847 | DBMET01847 | |
| 0.047 | 0.081 | 0.058 | Alpha adrenoreceptor agonist | 0.058 0.057 DBMET01847 | DBMET01847 | |
| 0.023 | 0.057 | 0.038 | Diamine oxidase inhibitor | 0.038 0.026 DBMET01847 | DBMET01847 | |
| 0.013 | 0.051 | 0.139 | Retinoic acid beta receptor agonist | 0.139 0.003 DBMET01847 | DBMET01847 | |
| 0.138 | 0.176 | 0.167 | Vasodilator | 0.166 0.136 DBMET01845 0.167 0.135 DBMET01846 | DBMET01846 | |
| 0.03 | 0.077 | 0.06 | Microtubule stabilization | 0.06 0.014 DBMET01847 | DBMET01847 | |
| 0.104 | 0.152 | 0.188 | Growth hormone agonist | 0.188 0.064 DBMET01847 | DBMET01847 | |
| 0.005 | 0.053 | 0.026 | Kainate receptor 1 antagonist | 0.026 0.012 DBMET01847 | DBMET01847 | |
| 0.011 | 0.067 | 0.04 | Leukotriene B4 receptor 1 antagonist | 0.04 0.012 DBMET01847 | DBMET01847 | |
| 0.017 | 0.075 | 0.064 | Kainate receptor antagonist | 0.064 0.014 DBMET01847 | DBMET01847 | |
| 0.019 | 0.083 | 0.061 | Inosine monophosphate dehydrogenase inhibitor | 0.061 0.01 DBMET01847 | DBMET01847 | |
| 0.144 | 0.211 | 0.175 | Peptidyltransferase inhibitor | 0.175 0.138 DBMET01847 | DBMET01847 | |
| 0.042 | 0.111 | 0.065 | Neuraminidase (influenza) inhibitor | 0.065 0.042 DBMET01847 | DBMET01847 | |
| 0.013 | 0.083 | 0.06 | Kainate receptor 2 antagonist | 0.06 0.012 DBMET01847 | DBMET01847 | |
| 0.009 | 0.08 | 0.044 | Sphingosine 1-phosphate receptor 3 agonist | 0.044 0.019 DBMET01845 0.042 0.02 DBMET01846 | DBMET01845 | |
| 0.07 | 0.149 | 0.104 | Toll-Like receptor 4 antagonist | 0.104 0.063 DBMET01845 | DBMET01845 | |
| 0.168 | 0.249 | 0.242 | Antiobesity | 0.21 0.197 DBMET01845 0.242 0.165 DBMET01846 | DBMET01846 | |
| 0.008 | 0.096 | 0.222 | Retinoid X beta receptor agonist | 0.222 0.002 DBMET01847 | DBMET01847 | |
| 0.055 | 0.149 | 0.083 | Aminoacyl-tRNA synthetase inhibitor | 0.083 0.071 DBMET01847 | DBMET01847 | |
| 0.034 | 0.134 | 0.083 | Factor III inhibitor | 0.083 0.007 DBMET01847 | DBMET01847 | |
| 0.039 | 0.144 | 0.081 | Bcl2 antagonist | 0.081 0.031 DBMET01845 | DBMET01845 | |
| 0.024 | 0.131 | 0.068 | Neuraminidase inhibitor | 0.068 0.035 DBMET01847 | DBMET01847 | |
| 0.083 | 0.232 | 0.292 | Antimitotic | 0.292 0.046 DBMET01847 | DBMET01847 | |
| 0.051 | 0.217 | 0.12 | Transcription factor NF kappa B stimulant | 0.12 0.025 DBMET01847 | DBMET01847 | |
| 0.005 | 0.182 | 0.034 | Squalene synthetase inhibitor | 0.034 0.021 DBMET01847 | DBMET01847 | |
| 0.006 | 0.261 | 0.014 | DNA polymerase III polC-type inhibitor | 0.014 0.008 DBMET01847 | DBMET01847 | |
| 0.011 | 0.346 | 0.027 | DNA polymerase III inhibitor | 0.027 0.022 DBMET01847 | DBMET01847 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |